Colorado Suspends Youth Medicaid Gender Care Oct 13

“Any ability to resume covering gender affirming care will require legislative action,” the Colorado Department of Health Care and Financing said in a statement.

The state will suspend Medicaid coverage for hormone therapy and other gender-affirming care for youth starting Oct. 13. This move follows a new federal rule finalized earlier this month. The rule blocks federal funds from paying for these treatments for young people.

Specifically, the suspension applies to those under 18 on Medicaid and those under 19 on CHP+, Colorado’s version of the Children’s Health Insurance Program.

The affected services include hormone therapy and puberty blockers. Other procedures are also impacted. Behavioral healthcare remains exempt.

Colorado’s Department of Health Care Policy and Financing, known as HCPF, administers the state's Medicaid program. The agency confirmed it is working with the Attorney General’s Office to support impacted members and providers through these changes.

In the 2024-25 fiscal year, about 500 people under age 19 received hormone therapy covered by Medicaid. This was part of gender-affining treatment linked to a diagnosis of gender dysphoria. That is the most recent complete data available from HCPF.

A handful of others received different types of gender-affirming care. These fell under “procedures” (doctor services) or “inpatient” (hospital services). The inpatient category likely includes gender-affirming surgeries, though HCPF did not provide a detailed breakdown of claims.

The department did not offer similar data for youth on CHP+.

Colorado covers around 450,000 children on Medicaid. The number of young people receiving hormones for gender-affirming care represents about 0.1% of the total caseload. Another 70,000 people are enrolled in CHP+, which also covers pregnant women.

The cost to provide this coverage is not huge compared with HCPF’s overall budget. The program stood at roughly $16 billion in 2024-25 and has risen to more than $20 billion.

In 2024-25, Colorado’s Medicaid program spent a little under $1.3 million on gender-affirming care for people under 19. About $700,000 of that came from federal funds.

Under the federal rule, patients currently taking hormones will keep their coverage for a six-month tapering period. This gives families time to adjust.

The suspension begins Oct. 13 to match the federal effective date.

Feinsinger wrote in the Colorado Sun that the department is actively planning for this transition. The key takeaway is the legislative hurdle. Without new laws, resuming coverage will be difficult.

Locals should watch for how the Attorney General’s Office coordinates with HCPF. The state is trying to minimize disruption during the transition.

The financial impact on individual families may be small in aggregate, but for those 500 youth, the change is immediate. They will need to navigate a new payment structure once the six-month window closes.

Make no mistake: this is about federal money, but it’s local care. The state is pulling back on what it pays for directly. It leaves the question of who picks up the tab when federal dollars dry up.